# The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

> **NCT03364335** · PHASE2 · COMPLETED · sponsor: **NuSirt Biopharma** · enrollment: 267 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Leu Sil 1.0mg
- **DRUG:** Leu Sil 4.0mg
- **DRUG:** Leu Met Sil 1.0mg
- **DRUG:** Leu Met Sil 4.0mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03364335
- **Lead sponsor:** NuSirt Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-08
- **Primary completion:** 2018-08-06
- **Final completion:** 2018-08-17
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03364335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03364335, "The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03364335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*